TCM
TCG Crossover Management’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.93M | Hold |
584,955
| – | – | 0.45% | 32 |
|
|
2025
Q1 | $5.29M | Hold |
584,955
| – | – | 0.72% | 31 |
|
|
2024
Q4 | $10.1M | Hold |
584,955
| – | – | 0.99% | 30 |
|
|
2024
Q3 | $9.35M | Hold |
584,955
| – | – | 0.79% | 26 |
|
|
2024
Q2 | $8.34M | Hold |
584,955
| – | – | 0.87% | 24 |
|
|
2024
Q1 | $8.29M | Hold |
584,955
| – | – | 0.66% | 28 |
|
|
2023
Q4 | $8.83M | Hold |
584,955
| – | – | 0.98% | 24 |
|
|
2023
Q3 | $9.24M | Hold |
584,955
| – | – | 1.36% | 22 |
|
|
2023
Q2 | $8.86M | Hold |
584,955
| – | – | 1.45% | 17 |
|
|
2023
Q1 | $8.48M | Hold |
584,955
| – | – | 1.65% | 16 |
|
|
2022
Q4 | $7.91M | Sell |
584,955
-57,234
| -9% | -$774K | 1.4% | 17 |
|
|
2022
Q3 | $10.1M | Sell |
642,189
-21,505
| -3% | -$339K | 3.04% | 10 |
|
|
2022
Q2 | $8.08M | Hold |
663,694
| – | – | 3.43% | 10 |
|
|
2022
Q1 | $6.13M | Hold |
663,694
| – | – | 2.46% | 16 |
|
|
2021
Q4 | $11.4M | Buy |
+663,694
| New | +$11.4M | 5.32% | 9 |
|